Report Description of the APAC Women Health Diagnostic Market Analysis
Research Scope and Assumption
- The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
- The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
- We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
- All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
- Inflation has not been accounted for in order to estimate and forecast the market
- Numbers may not add up due to rounding off
Reason to buy the report:
- Facilitate decision-making based on strong current and forecast data for APAC Women Health Diagnostic Market Analysis
- Develop strategies based on the latest regulatory framework
- Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
- Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the APAC Women Health Diagnostic Market Analysis
- Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
- To strategically profile key players and comprehensively analyze their market shares and core competencies
- We have technically sound team which do a deep dive research and also provide strategy based consulting analysis
APAC Women Health Diagnostic Market Analysis Executive Summary
Asia-Pacific women health diagnostics market is growing at a CAGR of approximately 9.7% during the forecast period. The Asia-Pacific is one of the developed economies of the world, according to World Bank, the GDP of Asia-Pacific is around $24.5 trillion in the year 2018, which indicates huge growth opportunities for the multinational players to invest. Increasing health infrastructure in developing countries such as China and India is estimated to fuel the growth of the women health diagnostic market. One of the major reasons for the growth of the GDP of APAC is remittance received from foreign nations.
Market Size and Key Findings
The APAC Women Health Diagnostic Market Analysis size stood at around USD 33.9 billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 9.7% during the forecast period.
The size of the APAC Women Health Diagnostic Market is expected to worth USD xx billion by 2028 from USD 33.92 billion in 2020, showcasing a CAGR of 9.7% from 2021 to 2028.
Market Growth Drivers Analysis
The declining fertility rate in the Asia Pacific region is also one of the major factors that are driving the growth of the Asia-Pacific women health diagnostics. Over the last decade, a decline in fertility rates in the Asia Pacific region has been witnessed. Urbanization and changing lifestyle is one of the major factors that are responsible for infertility. Lifestyle factors such as alcohol, smoking, caffeine, stress, weight are the major factors that affect the fertility.
Increasing incidences of the CVD among women in the Asia Pacific region is estimated to be the major factor that is contributing significantly towards the growth of the Asia-Pacific women health diagnostics market. Cardiovascular diseases have become a major health threat in the Asia Pacific region. It was estimated that non-communicable cardiovascular diseases account for 7 out of 10 fatalities in developing countries. Moreover, increasing incidences of breast cancer in the Asia Pacific region is also augmenting the demand of the Asia-Pacific women health diagnostics market. Breast cancer has emerged as a major health issue in the Asia-Pacific region. Australia is estimated to have the highest rate of breast cancer incidences in the APAC region. Obesity, alcohol consumption and smoking are some of the major factors that are backing the increasing prevalence of breast cancer in Australia.
COVID-19 impact on “APAC Women Health Diagnostic Market Analysis”
Since the beginning of 2020, more and more countries across the globe shut down their borders and limited transportation and travel to contain the coronavirus (COVID-19) outbreak, thus, creating impediments for international trade and transportation. This had disrupted the supply chains for the women’s health diagnostics market, temporarily leading to fall in demand due to uncertainty in the global economy and capital markets.
The key players operating in the women health diagnostics market include Abbott Laboratories, Inc., biomerieux SA, Becton, Dickson and Co., DIALAB Gmbh, F. Hoffmann-La Roche Ltd., Fujifilm Holdings Corp., Siemens AG, Quest Diagnostics Inc., and General Electric Co. Various collaborations among key players, governments, and other agencies to enhance accessibility of patients to diagnostics of various diseases poised to bolster the growth of the market.
Products in Pipeline
- In 2021, F. Hoffmann-La Roche Ltd. Launched the uPath HER2 (4B5) Image Analysis and uPath Dual ISH Image Analysis.
- In 2021, Hologic, Inc. acquired Biotheranostics, a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, to strengthen its presence in the women’s health diagnostics market.
Notable Recent Deals
- In 2014, Roche announced, the Global Access Program for increased access to HIV diagnostics. Roche partnered with national governments, local healthcare facilities, communities and international agencies, including UNAIDS, CHAI, Unitaid, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), Global Fund, and Center for Disease Control and Prevention (CDC), to establish programs that would go beyond providing diagnostic tests.
Healthcare Policies and Regulatory Landscape
Policy changes and Reimbursement scenario
- Access to safe and legal abortion is a pressing health and rights issue in Asia. Approximately 40 percent of abortions performed in 2008 in Asia were unsafe; in South Central Asia, South-eastern Asia and Western Asia, the percentage of those that were unsafe reached 60 to 65 percent. An estimated 17,000 women died from unsafe.
- On September 23, governments committed to deliver universal health coverage to all by 2030. Despite strong commitments to gender equality and reproductive rights, negotiations for the declaration were repeatedly threatened by the United States and other ideologically driven actors.
- IWHC-The International Women’s Health Coalition spoke with our grantee partner Sama, a resource group based in India, about its work to improve maternal health and rights through research, fact finding, and advocacy. IWHC has funded and supported Sama since 2016, and we have partnered in global advocacy spaces for more than two decades.